What are the main marketing models of domestic vaccine companies?

Companies have formed marketing organizations supported by technical and veterinary business experts to provide in-depth technical medical appraisal and outbreak guidance to customers. A company's direct sales relationships and global direct sales channels enable a high level of local and regional specialization, which allows it to quickly capitalize on market contingencies and provide a platform for R&D and business expansion. The importance foreign firms place on direct sales relationships enables them to achieve both good customer relationships and strong financial returns.　　Government Bidding and Procurement Categorized by channel, government bidding and procurement accounts for more than 60% of China's sales model, and is the main sales model in China. At present, China's strong immunization vaccine accounts for 68.47% of the entire biological products market, of which the sales of mandatory immunization for swine is 2.588 billion yuan, poultry is 1.269 billion yuan, and cattle and sheep is 397 million yuan. The share of swine vaccines in the whole swine vaccine market was 83.27%. Strong immunization vaccine for poultry accounted for 48.16% of the poultry market, with a high degree of marketization.　　In China's compulsory immunization program, five immunized species, including chicken Newcastle disease and brucellosis, have a history of returning to the market from tendered vaccines. Compared with 2008, the current mandatory immunization program has only increased one immunized species of porcine blue ear, while five species of chicken Newcastle disease and rabies have not appeared in the program.　　China's mandatory immunization program was formulated according to the epidemic situation and assessment standards in recent years. With the gradual stabilization of the epidemic situation of some diseases, the possibility of the country to include them in the compulsory immunization plan again is greatly reduced. The immunized species currently within the compulsory immunization plan still have high morbidity rates in recent years, and unless the epidemic situation tends to stabilize in recent years, the current compulsory immunization plan will not be significantly changed before the first phase of the assessment target is reached in 2015.　　Direct sales to large customers Large customers refer to grouped, large-scale breeding enterprises, most of which are national, provincial and municipal rated leading breeding enterprises, such as Guangdong Wenshi, Zhengda Group, Dacheng Group, Henan Yongda Group, Jilin Deda, Henan Daiyong Group, Shandong Minhe Group and so on. Matching the trend of China's farming scale, the number of domestic scale suppliers continues to increase, and the market share of scale enterprises now accounts for more than 50%. The marketing model adapted to the needs of large-scale enterprises will play an increasingly significant role in future market competition.　　Group, large-scale farming enterprises have a large demand and a strong sense of active epidemic prevention, the company generally adopts a direct marketing approach. Due to the higher incidence of epidemics in large-scale farming and increased awareness of food safety, large-scale farming enterprises have higher requirements for the quality of veterinary drugs, and their market share is generally occupied by high-quality veterinary drug companies. We believe that the marketing ability for large customers is an important factor in determining the growth prospects of domestic animal protection enterprises, with marketing advantages of the enterprise will be in the trend of large-scale farming to seize the market opportunity.　　Network distribution In addition to large-scale aquaculture enterprises, China's small-scale farming and free-range farming still occupy a large proportion. For small-scale farming customers, enterprises generally use the network distribution model.　　Veterinary drug distributors mainly include breeding service organizations and veterinary clinics with veterinary drug business qualification. According to national veterinary drug regulations, dealers must obtain veterinary drug (veterinary biological products) business licenses issued by provincial and municipal veterinary drug authorities. Distributors of veterinary pharmaceutical companies are generally close to the end market, providing product support or animal healthcare services to local farming enterprises and farmers, and have a certain degree of market influence in the local farming industry.　　With the increase in concentration of the downstream aquaculture industry and the growth in demand for animal protection services by farming enterprises, the proportion of network distribution model lacking complete product pool and service capabilities in the marketing channel will gradually decline.